GSM Foils Ltd · NSE:GSMFOILS
GSM Foils — H1 FY26 Earnings Presentation
30 slides from GSM Foils's earnings presentation, October 2025
Slide 1: GSM Foils Ltd Investor Presentation
GSM Foils Ltd Investor Presentation – October 2025 Investor Presentation – FY25 1
Slide 2: Company Overview
Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance
Slide 3: GSM Foils At A Glance
GSM Foils At A Glance • Established in 2019, GSM Foils specializes in the manufacturing of a wide range of Blister Foils and Aluminium Pharma Foils for the pharmaceutical industry. • We source raw materials from reputed, industry-recognized vendors, ensuring consistency and reliability in product qu
Slide 4: Company Snapshot
Company Snapshot 2019 14+ 7,973 Sq Ft 10,000+ Presence in States Manufacturing Area MT/Annum Year of Establishment Production Capacity ISO 20 – 40 110.13 Cr 8.23 Cr 9001:2015 Microns H1-FY26 Revenue H1-FY26 PAT Certification Product Range 10+ 72+ 39 In-House Advance Units Client Base Employees QA De
Slide 5: Our Journey
Our Journey Formed company Touched almost Converted LLP firm to Achieved the in the name of 80 % of our public limited and milestone of crossing GSM FOILS LLP capacity during shifted to new 100 Cr+ Annual and started peak covid and did premises of 15000 sq Turnover aluminum foil a healthy business f
Slide 6: Product Portfolio
Product Portfolio Blister Foil Aluminium Strip Pharma Foils Blister Pack Formation Superior Protection Consist of a thermoformed plastic tray or cold- Aluminium foils provide complete insulation formed tray sealed with aluminium foil or plastic against light, gases, moisture, and germs, ensuring lid
Slide 7: Blister Foils
Blister Foils Push-Through Blister Peel-Push Blister Packaging Packaging Medication is dispensed by peeling Medication is released by tearing open back the lidding and pushing through the package, constructed from paper, the aluminium foil; lidding is layered PET, and aluminium foil/HSC. with paper
Slide 8: Aluminium Strip Pharma Foils
Aluminium Strip Pharma Foils 30-micron Strip Foil 40-micron Strip Foil A thicker 40-micron aluminum foil A 30-micron aluminum foil with 150 with 150 GSM LDPE, providing GSM LDPE, designed for standard enhanced strength and barrier pharmaceutical packaging. properties. Used for packaging moisture-sen
Slide 9: Comprehensive Quality Control Measures
Comprehensive Quality Control Measures Bursting Strength Test GSM Calculator Measures the maximum pressure required to rupture the foil, ensuring Calculates the grammage per square meter, ensuring material consistency durability. and quality. Peeling Strength Test Digital Controlled Hot Plate Assess
Slide 10: Well Equipped Manufacturing Facility – Vasai, Maharashtra
Well Equipped Manufacturing Facility – Vasai, Maharashtra 1. Fully Equipped Multi-Storey Facility Our manufacturing unit, spread across 7,973 sq. ft. in Vasai, Mumbai, consists of three floors and a ground level. It is designed to support end-to-end operations including R&D, production, quality test
Slide 11: Delivering Value Through Quality, Customization, and Innovation
Delivering Value Through Quality, Customization, and Innovation Quality Assurance Tailored Client Product Innovation Vertical Integration & Compliance Solutions Ensures top-quality products Offers customized packaging and Strong supplier partnerships Continuous investment in R&D through advanced tes
Slide 12: Our Management Team
Our Management Team Mohansingh L Parmar Sagar Girish Bhanushali Managing Director CFO, Whole Time Director 12 • Completed Primary Education under the • Holds a Bachelor’s Degree in Commerce from the Maharashtra State Board and FYJC from P.D. Lions University of Mumbai (2015). College of Commerce & E
Slide 13: Certifications
Certifications ISO CERTIFICATE RESIDUAL -SOLVENT DECLARATION TSE/BSE DECLARATION FOOD GRADE DECLARATION BIS CERTIFICATE CGMP CERTIFICATE 13 Investor Presentation - H1 FY26
Slide 14: Industry Overview
Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance
Slide 15: India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging
India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging India: A Growing Market for Aluminium Foils Global Aluminium Foil Market: Expanding Horizons • Global market size estimated at USD 30+ billion • India is one of the largest consumers of aluminium foils in Asia • Major Market
Slide 16: Industry Tailwinds for Aluminium Foils in Pharma Applications
Industry Tailwinds for Aluminium Foils in Pharma Applications Rising Growth in Generic Regulatory Push for Innovation in Drug Biosimilars & Pharmaceutical Drugs & OTC Market Tamper-Proof, Delivery – Rise in Biologics Boom Exports from India Barrier-Grade Blister Packaging Packaging • India exported
Slide 17: Strategic Overview
Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance
Slide 18: Our Strategic Growth Roadmap
Our Strategic Growth Roadmap 1 4 We aim to strengthen our footprint across We plan to expand into Lamitube manufacturing India by entering new and underpenetrated within the pharmaceutical packaging sector, regions. This strategic move is expected to enabling value addition, improved margin unlock f
Slide 19: Our Core Strengths
Our Core Strengths 4 Operational Excellence 2 1 To remain cost-competitive and improve profitability, we continuously work on optimizing internal processes. Our 24-hour manufacturing operation ensures productivity across three shifts. We also focus on process 3 4 improvements, better inventory contr
Slide 20: Half-Yearly Financial Performance
Company Overview Industry Overview Strategic Overview Half-Yearly Financial Performance Historical Financial Performance
Slide 21: Q2 FY26 – Performance Highlights
Q2 FY26 – Performance Highlights Revenue (INR Lacs) EBITDA (INR Lacs) PAT (INR Lacs) +107.18% +86.48% +107.32% 5,814 439 664 3,118 212 320 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Segmental Bifurcation (In %) (Q2FY26) EBITDA Margins (In %) PAT Margins (In %) +115 bps +76 bps 35% 11.43% 7.56% 6.80%
Slide 22: Half-Yearly Income statement
Half-Yearly Income statement Particulars (In INR Lacs) Q2 FY26 Q2 FY25 Y-o-Y Q1 FY26 Q-o-Q H1 FY26 H1 FY25 Y-o-Y Revenue from Operations 5,813.59 3,117.60 86.48% 5,200.03 11.80% 11,013.62 5,217.19 111.10% Cost of Materials consumed 5,369.92 2,729.03 4,700.04 10,069.96 4,667.71 Changes in Inventories
Slide 23: Half-Yearly Balance Sheet
Half-Yearly Balance Sheet Equity & Liabilities(In INR Lacs) Mar-25 Sep-25 Assets(In INR Lacs) Mar-25 Sep-25 Shareholders' Fund Non ‐ Current Assets (a) Equity share capital 1,281.17 1,409.27 Property, plant and equipment (b) Other equity 1,843.08 4,825.67 (i)Tangible Assets 211.91 196.68 Total Equit
Slide 24: Half-Yearly Cash Flow Statement
Half-Yearly Cash Flow Statement Particulars (In INR Lacs) Mar-25 Sep-25 Cash Flow from Operating Activities Profit before Tax 1,362.82 1111.95 Adjustment for Non-Operating Items 28.2 19.56 Operating Profit before Working Capital Changes 1,391.02 1,131.51 Changes in Working Capital -3,291.77 -2,801.3
Slide 25: Historical Financial Performance
Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance
Slide 26: Historical Income statement
Historical Income statement Particulars (In INR Lacs) FY24* FY25 H1 FY26 Revenue from Operations 4,083.39 13,379.99 11,013.62 Cost of Materials consumed 3,557.25 11,585.95 10,069.96 Changes in Inventories of finished goods, work-in-progress and stock-in-trade (250.43) (398.44) -667.78 Gross Profit 7
Slide 27: Historical Balance Sheet
Historical Balance Sheet Equity & Liabilities(In INR Lacs) Mar-24 Mar-25 Sep-25 Assets(In INR Lacs) Mar-24 Mar-25 Sep-25 Shareholders' Fund Non ‐ Current Assets (a) Equity share capital 937.17 1,281.17 1,409.27 Property, plant and equipment (b) Other equity 166.09 1,843.08 4,825.67 (i)Tangible Asset
Slide 28: Historical Cash Flow Statement
Historical Cash Flow Statement Particulars (In INR Lacs) Mar-24 Mar-25 Sep-25 Cash Flow from Operating Activities Profit before Tax 185.25 1,362.82 1111.95 Adjustment for Non-Operating Items 13.26 28.20 19.56 Operating Profit before Working Capital Changes 198.51 1,391.02 1131.51 Changes in Working
Slide 29: Growth in Key Ratios
Growth in Key Ratios Revenue (INR Lacs) EBITDA (INR Lacs) and EBITDA Margin (%) PAT (INR Lacs) and PAT Margin (%) 13,380 1,521 965 11,014 1,246 823 11.36% 11.32% 7.47% 6.61% 7.21% 3.35% 4,083 270 137 FY24 FY25 H1 FY26 FY24 FY25 H1 FY26 FY24 FY25 H1 FY26 ROCE (%) ROE (%) Working Capital Days 30.88% 9
Slide 30: Thank You
GSM Foils Limited CIN: U43303MH2023PLC405459 Email ID: investors@gsmfoils.com Tel: +9184689 68102 Thank You Website: www.gsmfoils.com Investor Relations Partner X-B4 Advisory LLP Rasika Sawant / Aagam Shah Tel: +91 95944 57518 / +91 8850166932 Email ID: rasika@x-b4.com / aagam@x-b4.com Website: www.